Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies ...
Bondi’s Epstein Hearing Transcript, Lawmakers Target ‘Anti-Weaponization' Fund, Trump’s Coal Investment and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results